关键词: TET2 cytogenetic abnormality hypermethylation hypomethylating therapy miR-22 myelodysplastic syndrome (MDS)
Mesh : Adult Aged Aged, 80 and over Antimetabolites, Antineoplastic Azacitidine / therapeutic use Biomarkers / metabolism DNA Methylation / drug effects DNA-Binding Proteins / genetics metabolism Decitabine / therapeutic use Dioxygenases Female Humans Male MicroRNAs / biosynthesis genetics Middle Aged Mutation Myelodysplastic Syndromes / drug therapy genetics metabolism pathology Proto-Oncogene Proteins / genetics metabolism Survival Rate Treatment Outcome Young Adult
来 源:
DOI:10.3390/cimb43020065
PDF(Sci-hub)